PCSK9: the Critical Role of Familial Hypercholesterolemia from Discovery to Benefit for all

This publication has 31 references indexed in Scilit:

• Effect of a Monoclonal Antibody to PCSK9 on Low-Density Lipoprotein Cholesterol Levels in Statin-Intolerant Patients
  JAMA, 2012
• Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
  Nature Genetics, 2003
• Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
  New England Journal of Medicine, 1995
• Inhalation of levomepromazine in severe acute asthma
  The Lancet, 1994
• Effect of Partial Ileal Bypass Surgery on Mortality and Morbidity from Coronary Heart Disease in Patients with Hypercholesterolemia
  New England Journal of Medicine, 1990
• Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.
  Circulation, 1984
• Effects of an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase on Serum Lipoproteins and Ubiquinone-10 Levels in Patients with Familial Hypercholesterolemia
  New England Journal of Medicine, 1981
• THE LOW‐DENSITY LIPOPROTEIN PATHWAY IN HUMAN FIBROBLASTS: RELATION BETWEEN CELL SURFACE RECEPTOR BINDING AND ENDOCYTOSIS OF LOW‐DENSITY LIPOPROTEIN*
  Annals of the New York Academy of Sciences, 1976
• Lowering of Cholesterol Absorption and Blood Levels by Ileal Exclusion
  Circulation, 1964
• Xanthomata, Hypercholesterolemia, Angina Pectoris.
  Acta Medica Scandinavica, 1938